Loading company…
Mamotest provides AI-based breast cancer screening and diagnostic services.
Mamotest offers a platform for early breast cancer screening and diagnosis, alongside services such as 3D mammography, breast ultrasound and stereotactic biopsy. Founded in 2013, it is based in Buenos Aires, Argentina. The company raised USD 3.3 million in Series A funding led by Johnson & Johnson Impact Ventures in March 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in